Overview
Carla Dinardo practices in Sao Paulo, Brazil. Ms. Dinardo is highly rated in 6 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.
Her clinical research consists of co-authoring 82 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaMs. Dinardo isDistinguished. Learn about Anemia.
- Congenital Hemolytic AnemiaMs. Dinardo isDistinguished. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyMs. Dinardo isDistinguished. Learn about Hemoglobinopathy.
- Hemolytic AnemiaMs. Dinardo isDistinguished. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseMs. Dinardo isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- HemolysisMs. Dinardo isAdvanced. Learn about Hemolysis.
- Experienced
- ABO IncompatibilityMs. Dinardo isExperienced. Learn about ABO Incompatibility.
- AgranulocytosisMs. Dinardo isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaMs. Dinardo isExperienced. Learn about Alpha Thalassemia.
- Autoimmune Hemolytic AnemiaMs. Dinardo isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Bernard-Soulier SyndromeMs. Dinardo isExperienced. Learn about Bernard-Soulier Syndrome.
- COVID-19Ms. Dinardo isExperienced. Learn about COVID-19.